Physician profile
Caleb Jeon
NPI 1528558160
$2,176.45
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $194 · 2023: $1,405 · 2024: $578.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,982.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,982.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $986.87 | 2020-2024 | |
| Genzyme Corporation | $311.42 | 2020-2024 | |
| Regeneron Healthcare Solutions, INC. | $304.05 | 2020-2023 | Dupixent |
| E.R. Squibb & Sons, L.L.C. | $157.68 | 2023-2024 | Sotyktu |
| Lilly USA, LLC | $104.24 | 2023-2024 | Taltz, Olumiant |
| Sun Pharmaceutical Industries INC. | $81.88 | 2023-2024 | Winlevi, Absorica Ld |
| Pfizer INC. | $79.79 | 2023-2024 | |
| Dermavant Sciences, INC. | $59.78 | 2023-2024 | Vtama |
| Novartis Pharmaceuticals Corporation | $33.97 | 2023 | |
| Incyte Corporation | $26.80 | 2024 | Opzelura |
| Stemline Therapeutics INC. | $16.86 | 2020 | |
| Leo Pharma INC. | $13.11 | 2023 | Adbry |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caleb Jeon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.